A new peer-reviewed study shows that a back-relieving exosuit originally developed at Vanderbilt University and then commercialized by spin-off company HeroWear can simultaneously increase lifting endurance and reduce injury risk. This has important implications for the future of workplace safety and for workers in civilian and defense sectors.
The results of the study, conducted with U.S. Army Soldiers, were recently published by the journal Wearable Technologies. Vanderbilt biomedical researcher Katherine Rodzak and mechanical engineering Ph.D. student Paul Slaughter co-led the project, along with an interdisciplinary team, under the guidance of Karl Zelik, associate professor of mechanical and biomedical engineering and physical medicine and rehabilitation.
The objective of the study was to test whether a patented new back exosuit could increase a wearer's endurance when lifting heavy objects and to assess whether lifting more cancels out the exosuit's risk reduction benefits. The study found that 88% of participants increased their lifting repetitions while wearing an exosuit, with endurance increases ranging from 28% to 75%. The exosuit tested in the study, called SABER, was developed in close collaboration with U.S. Army Soldiers to support the field artillery and other logistics and sustainment operations in the military.
The study data was then used with an ergonomic assessment model to estimate the effects on cumulative back damage (an indicator of low back disorder risk) when an exosuit is worn and more lifts are performed. Participants exhibited 27% to 93% lower cumulative back damage when wearing an exosuit.
Studies show that back pain is the leading cause of disability in 160 countries. Furthermore, numerous reports in 2024 from organizations like the U.S. Government Accountability Office, U.S. Senate Committee on Health, Education, Labor, and Pensions, and National Employment Law Project called for more directed efforts to address high and costly workplace injury rates, particularly in logistics and warehousing sectors.
"These results confirmed that wearing an exosuit increased people's lifting ability without canceling out injury risk reduction benefits," said Zelik, who is also co-founder of HeroWear. "This scientific study affirms what we have been observing with workers wearing exosuits in warehouses and distribution centers. There is now converging evidence that these back exosuits can both boost productivity and reduce musculoskeletal disorder risks, which is huge for people who do hard physical work and for the organizations that employ them."
Zelik, who co-founded and co-directs the Center for Rehabilitation Engineering and Assistive Technology at Vanderbilt, started the Nashville-based workforce wearable technology company with two other Vanderbilt alumni, Matthew Yandell and Mark Harris.
Pioneering research and patented exosuit technology at Vanderbilt helped launch this endeavor to reduce back pain worldwide. Now, HeroWear's exosuit is one of the most widely used and scientifically-validated exoskeletons in the world, providing back relief to thousands of workers in over 30 countries around the globe. Last year, HeroWear introduced its newest civilian version of the exosuit, the Apex 2. Earlier this year, the Royal Australian Air Force (RAAF) ordered 470 additional Apex 2 exosuits, following previous purchases and pilot testing in 2023, to give its personnel an extra edge during their service.
HeroWear was recently named to Inc. magazine's 2024 "Best in Business" list for Innovation and Technology, in addition to receiving the top safety innovation award at the National Safety Council's annual congress and being recognized with the Product Startup of the Year Award at the Nashville Entrepreneur Center's NEXT Awards in 2024.
